Rein Therapeutics Competitors and Similar CompaniesClear all
Rein Therapeutics's competitors and similar companies include Seagen, iBio and Gliknik.
 Rein Therapeutics Rein Therapeutics (formerly known as Aileron Therapeutics) is a clinical-stage biopharmaceutical company that develops medicines targeting undruggable cancer sites using its proprietary platform of stabilized cell-permeating peptides. |  Seagen Seagen (formerly known as Seattle Genetics) is a biotechnology company that develops and commercializes targeted therapies to treat cancer. |  Gliknik Gliknik is a biopharmaceutical company creating therapies for people living with cancer and immune disorders. | ||
Founding Date | Founding Date 2005 | Founding Date 1998 | Founding Date 2008 | Founding Date 2007 |
Type | Type Public | Type Subsidiary | Type Public | Type Private |
Tags | ||||
Locations | Locations Watertown, US HQ Boston, US | Locations Bothell, US HQ Mississauga, CA Hørsholm, DK Rueil Malmaison, FR München, DE Milano, IT Schiphol, NL see more | Locations San Diego, US HQ Bryan, US | Locations Baltimore, US HQ |
Employees | Employees 838% decrease | Employees 3,25622% increase | Employees 1630% decrease | Employees 9 |
Valuation ($) | Valuation ($) 90.2 m | Valuation ($) N/A | Valuation ($) 26.2 m | Valuation ($) N/A |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $2b (FY, 2022) | Revenue (est.) $400k (FY, 2025) | Revenue (est.) N/A |
Net income | Net income ($49.9m) (FY, 2025) | Net income ($610.3m) (FY, 2022) | Net income N/A | Net income N/A |
Operating ⚠ | ||||
Patents Issued | Patents Issued 175 (May, 2017) | Patents Issued N/A | Patents Issued 67 (FY, 2016) | Patents Issued N/A |
Patents Pending | Patents Pending 205 (May, 2017) | Patents Pending N/A | Patents Pending 19 (FY, 2016) | Patents Pending N/A |
Funding | ||||
Total funding raised | Total funding raised $ 112m | Total funding raised $ 164m | Total funding raised $ 9.3m | Total funding raised $ 65.1m |
For sources of this data, please see the company profile
View Company Profiles
Seagen
HQ
Bothell, US
Seagen (formerly known as Seattle Genetics) is a biotechnology company that develops and commercializes targeted therapies to treat cancer.
View companyGliknik
HQ
Baltimore, US
Employees
9
Gliknik is a biopharmaceutical company creating therapies for people living with cancer and immune disorders.
View company